Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Circassia Pharmaceuticals ( (GB:NIOX) ) just unveiled an announcement.
Niox Group PLC, a part of the pharmaceutical industry, specializes in products and services related to healthcare, with a focus on diagnostics for respiratory conditions. The recent notification indicates a change in the voting rights, with Richard Griffiths and controlled holdings reducing their stake from 11.90% to 9.83% in Niox Group PLC. This adjustment in shareholding may impact the company’s governance and decision-making processes, potentially influencing its strategic direction.
More about Circassia Pharmaceuticals
YTD Price Performance: -2.54%
Average Trading Volume: 470,422
Technical Sentiment Consensus Rating: Hold
Current Market Cap: £244M
Learn more about NIOX stock on TipRanks’ Stock Analysis page.